A Review of First-Line Treatment for Small-cell Lung Cancer

@article{Murray2006ARO,
  title={A Review of First-Line Treatment for Small-cell Lung Cancer},
  author={N. Murray and A. Turrisi},
  journal={Journal of Thoracic Oncology},
  year={2006},
  volume={1},
  pages={270-278}
}
  • N. Murray, A. Turrisi
  • Published 2006
  • Medicine
  • Journal of Thoracic Oncology
  • Although small-cell lung cancer (SCLC) makes up a smaller proportion of all lung cancers than it did 25 years ago, it remains a common cause of cancer mortality that requires more clinical and basic research than is currently underway. Trials of newer chemotherapy variations have failed to produce a regimen that is clearly superior to the two-drug combination of etoposide and cisplatin, which remains the standard of care for both limited and extensive stage SCLC. Paradoxically, advances in this… CONTINUE READING
    102 Citations
    Small cell lung cancer.
    • 124
    Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
    • 4
    • PDF
    Novel systemic therapies for small cell lung cancer.
    • 28
    • PDF
    Update on targeted therapies for small cell carcinoma of the lung
    • 2
    [Analysis of Efficacy of Surgical Treatment for IIIa Small Cell Lung Cancer].
    • 1
    Update on small cell lung cancer management
    • 9
    • PDF

    References

    SHOWING 1-10 OF 77 REFERENCES
    Influence of age on the treatment of limited-stage small-cell lung cancer.
    • 141
    Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.
    • 437
    Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.
    • 96
    Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
    • R. Klasa, N. Murray, A. Coldman
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1991
    • 138
    Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
    • N. Murray, P. Coy, +7 authors P. Dixon
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1993
    • 628
    Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
    • 155